Physician shortage cutting into the bottom lines at hospitals

 

While healthcare executives have been worried about the high cost of implementing the Affordable Care Act, what's really keeping them up at night is the rising cost of labor caused by the declining number of physicians, according to Forbes.

Executives are saying that the cost of higher salaries is a bigger cost driver in their organizations than those associated with healthcare reform costs. 

Read more below:

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.